Log in

CVE:NXG - NexgenRx Stock Price, Forecast & News

C$0.19
0.00 (0.00 %)
(As of 01/26/2020 04:00 PM ET)
Today's Range
C$0.19
Now: C$0.19
C$0.19
50-Day Range
C$0.17
MA: C$0.19
C$0.22
52-Week Range
C$0.15
Now: C$0.19
C$0.33
Volume1,500 shs
Average Volume54,100 shs
Market CapitalizationC$13.28 million
P/E Ratio190.00
Dividend YieldN/A
BetaN/A
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; and direct deposit services. In addition, it offers ancillary services. NexgenRx Inc. was founded in 2003 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Health Care Plans
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6953393

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$9.48 million
Cash FlowC$0.01 per share
Book ValueC$0.03 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$13.28 million
Next Earnings Date4/13/2020 (Estimated)
OptionableNot Optionable

Receive NXG News and Ratings via Email

Sign-up to receive the latest news and ratings for NXG and its competitors with MarketBeat's FREE daily newsletter.


NexgenRx (CVE:NXG) Frequently Asked Questions

What is NexgenRx's stock symbol?

NexgenRx trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."

When is NexgenRx's next earnings date?

NexgenRx is scheduled to release their next quarterly earnings announcement on Monday, April 13th 2020. View Earnings Estimates for NexgenRx.

What price target have analysts set for NXG?

1 brokerages have issued twelve-month target prices for NexgenRx's stock. Their forecasts range from C$4.00 to C$4.00. On average, they anticipate NexgenRx's share price to reach C$4.00 in the next year. This suggests a possible upside of 2,005.3% from the stock's current price. View Analyst Price Targets for NexgenRx.

What is the consensus analysts' recommendation for NexgenRx?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NexgenRx in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for NexgenRx.

Has NexgenRx been receiving favorable news coverage?

Press coverage about NXG stock has been trending extremely negative this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. NexgenRx earned a daily sentiment score of -4.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for NexgenRx.

Who are some of NexgenRx's key competitors?

Who are NexgenRx's key executives?

NexgenRx's management team includes the folowing people:
  • Mr. Ronald C. Loucks, Founder, CEO, Pres & Director (Age 69)
  • Mr. Kelly Elher, Chief Financial Officer
  • Ms. Liliana Martino, National VP of Sales
  • Mr. Andrew Munroe, Director of Operations
  • Mr. Hugh C. Hart, VP of Sales & Account Management

How do I buy shares of NexgenRx?

Shares of NXG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is NexgenRx's stock price today?

One share of NXG stock can currently be purchased for approximately C$0.19.

How big of a company is NexgenRx?

NexgenRx has a market capitalization of C$13.28 million and generates C$9.48 million in revenue each year. View Additional Information About NexgenRx.

What is NexgenRx's official website?

The official website for NexgenRx is http://www.nexgenrx.com/.

How can I contact NexgenRx?

NexgenRx's mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The company can be reached via phone at +1-416-6953393.


MarketBeat Community Rating for NexgenRx (CVE NXG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  119
MarketBeat's community ratings are surveys of what our community members think about NexgenRx and other stocks. Vote "Outperform" if you believe NXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel